In filings with AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Gilead Sciences, Johnson & Johnson, Merck, Pfizer, and Regeneron, activist shareholders at the Interfaith Center on Corporate Responsibility (ICCR) are asking companies to weigh patient access when they're developing patent strategies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,